Skip to content

Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)

Examining Disparity Driven Vergence as a Potential Diagnostic Test for Mild Traumatic Brain Injury (mTBI)

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03529799
Enrollment
40
Registered
2018-05-18
Start date
2018-04-20
Completion date
2019-09-25
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Traumatic Brain Injury

Keywords

mTBI, TBI, brain injury, concussion

Brief summary

This study aims to determine the validity and safety of disparity driven vergence using a portable goggle system (I-PAS) using a pseudorandom ternary sequence of frequencies for testing.

Interventions

Portable, head-mounted display goggle system with integrated eye capture technology

Sponsors

University of Miami
Lead SponsorOTHER
Neurolign
CollaboratorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 to 65 * Both females and males

Exclusion criteria

* Central processing disorder * Impaired vision without corrective lenses (max 20/60 uncorrected) * Moderate to severe hearing loss (\>55 decibels (dB) pure tone audiometry (PTA), \<50% word identification) * Vestibular disorder except for patients recruited for subjects recruited with a history of mild traumatic brain injury to compare to normal participants * History of ear surgery other than myringotomy with or without tube placement * Pregnant women * Prisoners * Adults unable to consent

Design outcomes

Primary

MeasureTime frameDescription
Pseudorandom Ternary Sequence of Frequency15 minutesPseudorandom Ternary Sequence of Frequency (reported in Hertz) will be measured via mergence testing using the IPAS goggles.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMichael Hoffer, MD

University of Miami

Participant flow

Participants by arm

ArmCount
Injured Participants
Participants with mild traumatic brain injury (mTBI) tested using the I-PAS goggles I-PAS Goggles: Portable, head-mounted display goggle system with integrated eye capture technology
14
Uninjured Participants
Participants with no mild traumatic brain injury (mTBI) tested using the I-PAS goggles I-PAS Goggles: Portable, head-mounted display goggle system with integrated eye capture technology
26
Total40

Baseline characteristics

CharacteristicInjured ParticipantsUninjured ParticipantsTotal
Age, Continuous33.4 years
STANDARD_DEVIATION 9.7
36.3 years
STANDARD_DEVIATION 16.9
34.05 years
STANDARD_DEVIATION 12.2
Race/Ethnicity, Customized
Caucsian
Caucasian
4 Participants6 Participants10 Participants
Race/Ethnicity, Customized
Caucsian
Hispanic
8 Participants16 Participants24 Participants
Race/Ethnicity, Customized
Caucsian
Other
2 Participants4 Participants6 Participants
Sex: Female, Male
Female
8 Participants19 Participants27 Participants
Sex: Female, Male
Male
6 Participants7 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 26
other
Total, other adverse events
0 / 140 / 26
serious
Total, serious adverse events
0 / 140 / 26

Outcome results

Primary

Pseudorandom Ternary Sequence of Frequency

Pseudorandom Ternary Sequence of Frequency (reported in Hertz) will be measured via mergence testing using the IPAS goggles.

Time frame: 15 minutes

Population: All participants

ArmMeasureValue (MEDIAN)Dispersion
Injured ParticipantsPseudorandom Ternary Sequence of Frequency0.07 HertzStandard Deviation 0.69
Uninjured ParticipantsPseudorandom Ternary Sequence of Frequency0.1 HertzStandard Deviation 0.54

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026